Insulet (PODD)
(Real Time Quote from BATS)
$229.93 USD
-0.06 (-0.03%)
Updated Oct 4, 2024 12:52 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Income Statements
Fiscal Year end for Insulet Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,697 | 1,305 | 1,099 | 904 | 738 |
Cost Of Goods | 537 | 500 | 347 | 322 | 258 |
Gross Profit | 1,160 | 806 | 752 | 582 | 480 |
Selling & Adminstrative & Depr. & Amort Expenses | 940 | 768 | 626 | 531 | 430 |
Income After Depreciation & Amortization | 220 | 38 | 126 | 52 | 50 |
Non-Operating Income | 31 | -1 | -44 | 3 | -1 |
Interest Expense | 36 | 27 | 61 | 45 | 35 |
Pretax Income | 215 | 10 | 21 | 10 | 15 |
Income Taxes | 8 | 5 | 4 | 3 | 3 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 206 | 5 | 17 | 7 | 12 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 206 | 5 | 17 | 7 | 12 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 293 | 101 | 183 | 107 | 78 |
Depreciation & Amortization (Cash Flow) | 73 | 63 | 57 | 55 | 28 |
Income After Depreciation & Amortization | 220 | 38 | 126 | 52 | 50 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 73.63 | 69.91 | 68.58 | 65.95 | 62.30 |
Diluted EPS Before Non-Recurring Items | 2.75 | 1.28 | 0.24 | 0.10 | 0.19 |
Diluted Net EPS (GAAP) | 2.94 | 0.07 | 0.24 | 0.10 | 0.19 |
Fiscal Year end for Insulet Corporation falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | 488.50 | 441.70 | 509.80 | 432.70 | 396.50 |
Cost Of Goods | 157.60 | 134.90 | 148.60 | 139.40 | 131.60 |
Gross Profit | 330.90 | 306.80 | 361.20 | 293.30 | 264.90 |
SG&A, R&D, and Dept/Amort Expenses | 276.30 | 249.90 | 254.80 | 238.50 | 233.80 |
Income After SG&A, R&D, and Dept/Amort Expenses | 54.60 | 56.90 | 106.40 | 54.80 | 31.10 |
Non-Operating Income | 7.50 | 8.70 | 21.90 | 9.30 | -0.20 |
Interest Expense | 11.00 | 10.70 | 20.50 | 10.40 | 2.40 |
Pretax Income | 51.10 | 54.90 | 107.80 | 53.70 | 28.50 |
Income Taxes | -137.50 | 3.40 | 4.50 | 1.80 | 1.20 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 188.60 | 51.50 | 103.30 | 51.90 | 27.30 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 188.60 | 51.50 | 103.30 | 51.90 | 27.30 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | 73.80 | 73.74 | 73.61 | 73.62 | 70.14 |
Diluted EPS Before Non-Recurring Items | 0.55 | 0.73 | 1.40 | 0.71 | 0.38 |
Diluted Net EPS (GAAP) | 2.59 | 0.73 | 1.47 | 0.74 | 0.39 |